Stockreport

Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

Relay Therapeutics, Inc.  (RLAY) 
PDF CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing pot [Read more]